Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

Paulus Kirchhof, Karl Georg Haeusler, Benjamin Blank, Joseph De Bono, David Callans, Arif Elvan, Thomas Fetsch, Isabelle C. Van Gelder, Philip Gentlesk, Massimo Grimaldi, Jim Hansen, Gerhard Hindricks, Hussein R. Al-Khalidi, Tyler Massaro, Lluis Mont, Jens Cosedis Nielsen, Georg Nolker, Jonathan P. Piccini, Tom De Potter, Daniel ScherrUlrich Schotten, Sakis Themistoclakis, Derick Todd, Johan Vijgen, Luigi Di Biase

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2942-2955
Number of pages14
JournalEuropean Heart Journal
Volume39
Issue number32
DOIs
Publication statusPublished - 21 Aug 2018

Keywords

  • Atrial fibrillation
  • Ablation
  • Anticoagulation
  • Bleeding
  • Stroke
  • Brain MRI
  • HEART RHYTHM ASSOCIATION
  • VITAMIN-K ANTAGONISTS
  • CATHETER ABLATION
  • ANTICOAGULATION MANAGEMENT
  • RADIOFREQUENCY ABLATION
  • TRIAL
  • CRYOBALLOON
  • WARFARIN
  • THERAPY
  • LESIONS

Cite this

Kirchhof, P., Haeusler, K. G., Blank, B., De Bono, J., Callans, D., Elvan, A., Fetsch, T., Van Gelder, I. C., Gentlesk, P., Grimaldi, M., Hansen, J., Hindricks, G., Al-Khalidi, H. R., Massaro, T., Mont, L., Nielsen, J. C., Nolker, G., Piccini, J. P., De Potter, T., ... Di Biase, L. (2018). Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. European Heart Journal, 39(32), 2942-2955. https://doi.org/10.1093/eurheartj/ehy176